{
  "id": 7449155,
  "title": "Ani Pharmaceuticals director Thoma sells $71,530 in shares",
  "url": "https://urgent.news/2026/09/15/ani-pharmaceuticals-director-thoma-sells-71-530-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-15T02:15:54.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/ani-pharmaceuticals-director-thoma-sells-71530-in-shares-93CH-4900735"
  },
  "original_language": "en",
  "account": null,
  "summary": "ANI Pharmaceuticals director Jeanne Thoma sold 1,000 shares of the company's common stock on September 11, 2026, at a price of $71.53 per share, totaling $71,530. This sale was conducted pursuant to a Rule 10b5-1 trading plan adopted on June 12, 2026. Thoma currently holds 26,762 shares of ANI Pharmaceuticals common stock. The stock is trading near its 52-week low of $69.58, currently at $70.40, and is considered undervalued by InvestingPro analysis. Despite strong second-quarter 2026 results, with adjusted earnings of $2.21 per share and record revenue of $266 million, analysts have mixed opinions on the company's outlook, with some revising price targets and others maintaining a Hold rating.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}